Centene Corp DEF 14A: Executive Compensation Details
Ticker: CNC · Form: DEF 14A · Filed: 2024-03-28T00:00:00.000Z
Sentiment: neutral
Topics: executive-compensation, DEF14A, stock-awards
Related Tickers: CNC
TL;DR
Centene's 2023 exec comp is out - stock & equity awards detailed for LondonMember & NeidorffMember.
AI Summary
Centene Corp filed its DEF 14A on March 28, 2024, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on stock awards and equity awards granted to executive officers such as LondonMember and NeidorffMember, with reported values and vesting details for the period.
Why It Matters
This filing provides transparency into how Centene Corp compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal significant details about executive compensation, potential shareholder proposals, and board composition, which may impact stock performance.
Key Numbers
- 2023-12-31 — Fiscal Year End (Reporting period for executive compensation)
- 20240328 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Centene Corp (company) — Filer
- LondonMember (person) — Executive
- NeidorffMember (person) — Executive
FAQ
What is the total reported value of equity awards granted to LondonMember in 2023?
The filing indicates that for the period 2023-01-01 to 2023-12-31, the EquityAwardsReportedValueMember for LondonMember was reported.
What is the total value of stock awards for non-PEO members in 2023?
For the period 2023-01-01 to 2023-12-31, the StockAwardsTotalValueMember for NonPeoNeoMember is detailed.
What is the filing date of this DEF 14A?
The filing date is 20240328.
What fiscal year does this filing primarily cover?
This filing primarily covers the fiscal year ending 2023-12-31.
Are there details on equity awards granted in prior years that vested in 2023 for LondonMember?
Yes, the filing includes information on EquityAwardsGrantedInPriorYearsVestedMember for LondonMember for the period 2023-01-01 to 2023-12-31.
From the Filing
0001071739-24-000069.txt : 20240328 0001071739-24-000069.hdr.sgml : 20240328 20240328165609 ACCESSION NUMBER: 0001071739-24-000069 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 189 CONFORMED PERIOD OF REPORT: 20240514 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 24800038 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 DEF 14A 1 cnc-20240328.htm DEF 14A cnc-20240328 0001071739 DEF 14A false 0001071739 DEF 14A false 0001071739 2023-01-01 2023-12-31 0001071739 cnc:LondonMember 2023-01-01 2023-12-31 iso4217:USD 0001071739 cnc:NeidorffMember 2023-01-01 2023-12-31 xbrli:pure 0001071739 cnc:LondonMember 2022-01-01 2022-12-31 0001071739 cnc:NeidorffMember 2022-01-01 2022-12-31 0001071739 2022-01-01 2022-12-31 0001071739 cnc:NeidorffMember 2021-01-01 2021-12-31 0001071739 2021-01-01 2021-12-31 0001071739 cnc:NeidorffMember 2020-01-01 2020-12-31 0001071739 2020-01-01 2020-12-31 0001071739 ecd:PeoMember cnc:StockAwardsTotalValueMember cnc:LondonMember 2023-01-01 2023-12-31 0001071739 ecd:PeoMember cnc:EquityAwardsReportedValueMember cnc:LondonMember 2023-01-01 2023-12-31 0001071739 ecd:PeoMember cnc:EquityAwardsGrantedInPriorYearsMember cnc:LondonMember 2023-01-01 2023-12-31 0001071739 ecd:PeoMember cnc:EquityAwardsGrantedInPriorYearsVestedMember cnc:LondonMember 2023-01-01 2023-12-31 0001071739 cnc:StockAwardsTotalValueMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001071739 ecd:NonPeoNeoMember cnc:EquityAwardsGrantedAndVestedMember 2023-01-01 2023-12-31 0001071739 ecd:NonPeoNeoMember cnc:EquityAwardsReportedValueMember 2023-01-01 2023-12-31 0001071739 cnc:EquityAwardsGrantedInPriorYearsMember ecd:NonPeoNeoMember 2023-01-01 2023-12-31 0001071739 ecd:NonPeoNeoMember cnc:EquityAwardsGrantedInPriorYearsVestedMember 2023-01-01 2023-12-31 0001071739 1 2023-01-01 2023-12-31 0001071739 2 2023-01-01 2023-12-31 0001071739 ecd:PeoMember 2 2023-01-01 2023-12-31 0001071739 ecd:PeoMember 4 2023-01-01 2023-12-31 0001071739 ecd:PeoMember 1 2023-01-01 2023-12-31 0001071739 ecd:PeoMember 3 2023-01-01 2023-12-31 0001071739 ecd:PeoMember 5 2023-01-01 2023-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A (RULE 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.     )   Filed by the Registrant   x   Filed by a Party other than the Registrant   o    Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material Under §240.14a-12   CENTENE CORPORATION (Name of Registrant as Specified In Its Charter)   Payment of Filing Fee (Check all boxes that apply): x No fee required. o Fee paid previously with preliminary materials. o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Our Mission Transforming the health of the communities we serve, one person at a time. Since its founding as a single local healthcare plan in 1984, Centene's heart and soul has been linked to supporting the health of the communities we proudly serve. We are committed to providing access to quality, culturally sensitive care for our members and communities. Now, nearly forty years later, this long-held commitment to supporting the health and health care of our members is encapsulated in our mi